Literature DB >> 1677144

CD4 antibody treatment of severe psoriasis.

J F Nicolas, N Chamchick, J Thivolet, J Wijdenes, P Morel, J P Revillard.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1677144     DOI： 10.1016/0140-6736(91)90465-2

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  12 in total

1.  [Psoriasis therapy with biologicals].

Authors:  U Mrowietz
Journal:  Hautarzt       Date:  2003-02-11       Impact factor: 0.751

Review 2.  Immunological mechanisms involved in psoriasis.

Authors:  C E Griffiths; J J Voorhees
Journal:  Springer Semin Immunopathol       Date:  1992

Review 3.  Angiogenesis drives psoriasis pathogenesis.

Authors:  Regina Heidenreich; Martin Röcken; Kamran Ghoreschi
Journal:  Int J Exp Pathol       Date:  2009-06       Impact factor: 1.925

4.  Kinetics and regulation of human keratinocyte stem cell growth in short-term primary ex vivo culture. Cooperative growth factors from psoriatic lesional T lymphocytes stimulate proliferation among psoriatic uninvolved, but not normal, stem keratinocytes.

Authors:  Z Bata-Csorgo; C Hammerberg; J J Voorhees; K D Cooper
Journal:  J Clin Invest       Date:  1995-01       Impact factor: 14.808

Review 5.  New insights of T cells in the pathogenesis of psoriasis.

Authors:  Yihua Cai; Chris Fleming; Jun Yan
Journal:  Cell Mol Immunol       Date:  2012-06-18       Impact factor: 11.530

6.  Targeting T Cell Malignancies Using CD4CAR T-Cells and Implementing a Natural Safety Switch.

Authors:  Gina Ma; Jiaqi Shen; Kevin Pinz; Masayuki Wada; Jino Park; Soojin Kim; Tomiteru Togano; William Tse
Journal:  Stem Cell Rev Rep       Date:  2019-06       Impact factor: 5.739

7.  In vivo treatment with a monoclonal chimeric anti-CD4 antibody results in prolonged depletion of circulating CD4+ cells in chimpanzees.

Authors:  M Jonker; W Slingerland; G Treacy; P van Eerd; K Y Pak; E Wilson; S Tam; K Bakker; A F Lobuglio; P Rieber
Journal:  Clin Exp Immunol       Date:  1993-09       Impact factor: 4.330

8.  Th17 cytokines interleukin (IL)-17 and IL-22 modulate distinct inflammatory and keratinocyte-response pathways.

Authors:  K E Nograles; L C Zaba; E Guttman-Yassky; J Fuentes-Duculan; M Suárez-Fariñas; I Cardinale; A Khatcherian; J Gonzalez; K C Pierson; T R White; C Pensabene; I Coats; I Novitskaya; M A Lowes; J G Krueger
Journal:  Br J Dermatol       Date:  2008-08-05       Impact factor: 9.302

9.  Preclinical targeting of human T-cell malignancies using CD4-specific chimeric antigen receptor (CAR)-engineered T cells.

Authors:  K Pinz; H Liu; M Golightly; A Jares; F Lan; G W Zieve; N Hagag; M Schuster; A E Firor; X Jiang; Y Ma
Journal:  Leukemia       Date:  2015-11-03       Impact factor: 11.528

Review 10.  Jakpot! New small molecules in autoimmune and inflammatory diseases.

Authors:  Kamran Ghoreschi; Massimo Gadina
Journal:  Exp Dermatol       Date:  2014-01       Impact factor: 3.960
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.